drugset / Trial / NCT00229970

MK0476 Study in Adult Patients With Acute Asthma (0476-322)

NCT00229970

Phase 3 Completed 225 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.

Timeline

Start
2005-09
Primary completion
2006-10
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 7 mg Intravenous
Subject Montelukast Other / unclassified 14 mg Intravenous

Indications